USNA
Usana Health Sciences·NYSE
--
--(--)
--
--(--)
USNA fundamentals
Usana Health Sciences (USNA) expects to report earnings on Feb 17, 2026, with estimated revenue of 225.96M (YoY +5.78%), and EPS at 0.41 (YoY -35.94%).
Revenue estimate / YoY
225.96M
+5.78%
EPS estimate / YoY
0.41
-35.94%
Report date
Feb 17, 2026
EPS
Revenue
Revenue & Expenses
USNA has released its 2025 Q3 earnings report, with revenue of 213.67M, reflecting a YoY change of 6.72%, and net profit of -6.66M, showing a YoY change of -162.81%. The Sankey diagram below clearly presents USNA's revenue sources and cost distribution.
Key Indicators
Usana Health Sciences (USNA) key financial stats and ratios, covering profitability, financial health, and leverage.
Usana Health Sciences (USNA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Usana Health Sciences (USNA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Usana Health Sciences (USNA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Usana Health Sciences (USNA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Usana Health Sciences (USNA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Usana Health Sciences's revenue and profit?What is Usana Health Sciences's latest dividend and current dividend yield?What is the market's earnings forecast for Usana Health Sciences next quarter?What is the revenue and EPS growth rate for Usana Health Sciences year over year?What is Usana Health Sciences's gross profit margin?What does Usana Health Sciences do and what are its main business segments?What were the key takeaways from Usana Health Sciences’s earnings call?Did Usana Health Sciences beat or miss consensus estimates last quarter?
